Ternalys Therapeutics’ SAGUARO Platform provides a simple yet elegant way to simultaneously deliver multiple microRNAs, replenishing cancer cells with microRNAs that are present in normal cells but decreased in cancer cells - and thereby reversing the cancer’s defensive epigenetic changes. We have demonstrated the ability to synergistically enhance existing therapies and, by doing so, potentially alter the outcomes for many intractable cancers.
Company Details
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.ternalys.com
- Keywords
- Apollomics.
Ternalys Therapeutics, Inc Questions
Ternalys Therapeutics, Inc's website is http://www.ternalys.com
Ternalys Therapeutics, Inc's LinkedIn profile is https://www.linkedin.com/company/ternalys-therapeutics-inc
Ternalys Therapeutics, Inc's industry is
Biotechnology Research
Ternalys Therapeutics, Inc's top competitors are
Westwood & Wilshire Llc,
Apollomics,
Pro Chem Inc.,
Direct Customer Solutions,
Engeniusmicro,
Atmp Sweden,
An2 Therapeutics,
Bison Ventures,
Anacor Pharmaceuticals,
Fshd Society.
Ternalys Therapeutics, Inc's categories are Biotechnology Research
